Entera Bio Competitors and Similar CompaniesClear all
Entera Bio's competitors and similar companies include Ainos, Aerie Pharmaceuticals, Olpha and Momenta Pharmaceuticals.
 Entera Bio Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform. |  Ainos Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. |  Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. |  Momenta Pharmaceuticals Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. | |
Founding Date | Founding Date 2010 | Founding Date 1984 | Founding Date 2005 | Founding Date 1972 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Wellesley, US HQ Jerusalem, IL | Locations Amarillo, US HQ Taipei, TW | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US | Locations Olaine, LV HQ | Locations Cambridge, US HQ Dublin, IE Cambridge, US |
Employees | Employees 1616% decrease | Employees 4326% increase | Employees 3808% increase | Employees 2,191 | Employees 76 |
Valuation ($) | Valuation ($) 68.7 m | Valuation ($) 4.4 m | Valuation ($) 722.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $42k (FY, 2025) | Revenue (est.) $124.2k (FY, 2025) | Revenue (est.) $194.1m (FY, 2021) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) $23.9m (FY, 2019) |
Cost of goods | Cost of goods $42k (FY, 2025) | Cost of goods $21.2k (FY, 2025) | Cost of goods $26.8m (FY, 2021) | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $102.9k (FY, 2025) | Gross profit N/A | Gross profit €80.1m (FY, 2020) | Gross profit N/A |
Net income | Net income N/A | Net income ($14.8m) (FY, 2025) | Net income ($74.8m) (FY, 2021) | Net income €9.5m (FY, 2020) | Net income ($290.1m) (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Ainos
HQ
Amarillo, US
Employees
43↑ 26% increase
Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View companyOlpha
HQ
Olaine, LV
Employees
2,191
Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
View companyMomenta Pharmaceuticals
HQ
Cambridge, US
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules.
View company